Literature DB >> 9713045

677-->CT mutation on the methylenetetrahydrofolate reductase gene is not a risk factor for neural tube defects in Turkey.

K Boduroglu, M Alikasifoglu, B Anar, E Tuncbilek.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1998        PMID： 9713045      PMCID： PMC1720778          DOI： 10.1136/fn.78.3.f234c

Source DB:  PubMed          Journal:  Arch Dis Child Fetal Neonatal Ed        ISSN： 1359-2998            Impact factor:   5.747


× No keyword cloud information.
  4 in total

1.  Methylene tetrahydrofolate reductase genotype and the risk and extent of coronary artery disease in a population with low plasma folate.

Authors:  S L Tokgözoğlu; M Alikaşifoğlu; E Atalar; K Aytemir; N Ozer; K Ovünç; O Usal; S Kes; E Tunçbilek
Journal:  Heart       Date:  1999-05       Impact factor: 5.994

2.  Case series of thromboembolic complications in childhood nephrotic syndrome: Hacettepe experience.

Authors:  Betul Tavil; Fehime Kara; Rezan Topaloglu; Selin Aytac; Sule Unal; Baris Kuskonmaz; Mualla Cetin; Nesrin Besbas; Fatma Gumruk
Journal:  Clin Exp Nephrol       Date:  2014-07-04       Impact factor: 2.801

3.  PCMT1 gene polymorphisms, maternal folate metabolism, and neural tube defects: a case-control study in a population with relatively low folate intake.

Authors:  Fang Wang; Jianhua Wang; Jin Guo; Xiaoli Chen; Zhen Guan; Huizhi Zhao; Hua Xie; Chi Liu; Yihua Bao; Jizhen Zou; Bo Niu; Ting Zhang
Journal:  Genes Nutr       Date:  2013-08-06       Impact factor: 5.523

4.  Effects of MTHFR and ABCC2 gene polymorphisms on antiepileptic drug responsiveness in Jordanian epileptic patients.

Authors:  Laith N Al-Eitan; Islam M Al-Dalalah; Mohamed M Mustafa; Mansour A Alghamdi; Afrah K Elshammari; Wael H Khreisat; Hanan A Aljamal
Journal:  Pharmgenomics Pers Med       Date:  2019-06-10
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.